Scarica l'app Stockscreener
96.44
0.42%
-0.3717
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Abbott Laboratories Borsa (ABT) Ultime notizie
Abbott Laboratories stock (US0028241000): Why Google Discover changes matter more now - AD HOC NEWS
Bernstein SocGen cuts Abbott Labs stock price target on weak quarter - Investing.com Canada
Has the Abbott Laboratories Sell-Off Finally Created an Entry Point? - 24/7 Wall St.
Abbott price target lowered to $143 from $144 at Barclays - TipRanks
Market Crash: 2 Healthcare Stocks Worth Loading Up on at a Discount - The Motley Fool
Intuitive Surgical (ISRG) Q1 Earnings: What To Expect - TradingView
Abbott Laboratories stock (US0028241000): Is diagnostics strength enough to drive sustained growth f - AD HOC NEWS
Abbott Laboratories in charts: Medical Devices continues to see Y/Y double-digit growth momentum in Q1; nutrition falls - MSN
Notable healthcare headlines for the week: J&J, Abbott and Organon in focus - MSN
Assessing Abbott Laboratories (ABT) Valuation After Recent Share Price Weakness - simplywall.st
ABT: Abbott Laboratories Lowers Earnings Outlook Despite Revenue Beat - GuruFocus
How Abbott is Changing the Way We Treat AFib - Tomorrow's World Today
Abbott Laboratories (ABT) Margin Drop To 13.9% Challenges Bullish Earnings Narratives - simplywall.st
Ninety One UK Ltd Acquires New Stake in Abbott Laboratories $ABT - MarketBeat
Abbott Laboratories $ABT Shares Bought by Ninety One North America Inc. - MarketBeat
Abbott Laboratories $ABT Shares Sold by Lbp Am Sa - MarketBeat
Abbott Laboratories stock (US0028241000): Why diagnostics strength is suddenly worth a closer look - AD HOC NEWS
Abbott Laboratories (NYSE:ABT) Short Interest Up 19.4% in March - MarketBeat
Abbott Reaches Preliminary Settlement in Derivative Governance Case - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
[8-K] ABBOTT LABORATORIES Reports Material Event - Stock Titan
ABT Maintained by Piper Sandler -- Price Target Lowered to $115 - GuruFocus
Abbott Labs Stock (ABT) Hit with Slew of Downgrades After Earnings - TipRanks
Abbott Laboratories cuts outlook, says mild flu season hurt sales - MSN
China Diabetes Devices Market Forecast and Company Analysis Report 2026-2034 Featuring Roche, Abbott Laboratories, Novo Nordisk, BD, Medtronic, Eli Lilly, and Sanofi - Yahoo Finance
Abbott Laboratories Sales Growth Outlook 'Leaves Room For Upside': Analyst - Benzinga
Abbott stock crash: Rebound could be coming fast - MSN
Piper Sandler cuts Abbott Labs stock price target on weak diabetes sales - Investing.com
Abbott Stock Crash: Rebound Could Be Coming Fast - MarketBeat
TD Cowen lowers Abbott stock price target to $115 on guidance cut - Investing.com
ABT Maintained by Evercore ISI Group -- Price Target Lowered to $120 - GuruFocus
RBC Capital lowers Abbott Labs stock price target on Q1 results - Investing.com Australia
Abbott Labs’ Financial Results Narrowly Beat Forecasts - Baystreet.ca
A Quick Look at Today's Ratings for Abbott Laboratories(ABT.US), With a Forecast Between $115 to $144 - Moomoo
Abbott Laboratories (NYSE:ABT) Price Target Cut to $110.00 by Analysts at JPMorgan Chase & Co. - MarketBeat
Bernstein SocGen cuts Abbott Labs stock price target on growth concerns - Investing.com Canada
Citigroup Lowers Abbott Laboratories (NYSE:ABT) Price Target to $108.00 - MarketBeat
Wells Fargo Adjusts Price Target on Abbott Laboratories to $109 From $122, Maintains Overweight Rating - Moomoo
Oppenheimer Adjusts Price Target on Abbott Laboratories to $115 From $132, Maintains Outperform Rating - marketscreener.com
Abbott (ABT) Stock Price Prediction 2027: Analyst Targets, Q1 2026 Earnings & Bull/Bear Scenarios - techi.com
Abbott lowers EPS guidance on Exact Sciences buy as shares slide - Fierce Biotech
Citigroup Cuts Price Target on Abbott Laboratories to $108 From $136, Maintains Buy Rating - marketscreener.com
Benchmark Adjusts Price Target on Abbott Laboratories to $120 From $145, Maintains Buy Rating - marketscreener.com
JPMorgan Adjusts Price Target on Abbott Laboratories to $110 From $123, Maintains Overweight Rating - marketscreener.com
Benchmark cuts Abbott Labs stock price target on valuation to $120 - Investing.com
Oppenheimer cuts Abbott stock price target to $115 on guidance - Investing.com
Abbott Laboratories (NYSE:ABT) Q1 2026 Earnings Call Transcript - Insider Monkey
Why Is Abbott Stock Trending Lower? - Trefis
Abbott Price Prediction: Where Will the Stock Be in 2027 - 24/7 Wall St.
Why Abbott Laboratories stock tumbled on Thursday - MSN
Abbott Laboratories Stock Tumbles 6% On Weak Q2 Earnings Guidance - TIKR.com
BofA cuts Abbott Labs stock price target on growth concerns - Investing.com
BofA cuts Abbott Labs stock price target on growth concerns By Investing.com - Investing.com Australia
Mizuho Adjusts Price Target on Abbott Laboratories to $115 From $125, Maintains Neutral Rating - marketscreener.com
Evercore ISI Adjusts Price Target on Abbott Laboratories to $120 From $134, Maintains Outperform Rating - marketscreener.com
RBC Cuts Price Target on Abbott Laboratories to $130 From $135, Keeps Outperform Rating - marketscreener.com
Dr. Alexander Crider: There is a hidden cost to the Abbott verdict for premature babies - Chicago Tribune
Abbott price target lowered to $120 from $150 at BofA - TipRanks
Abbott Laboratories vs Medtronic: Which Stock Could Rally? - Trefis
Is Medtronic a Better Buy Than Abbott Laboratories? - Trefis
Abbott Laboratories (ABT) Q1 2026 Earnings Call Highlights: Stro - GuruFocus
ABT Stock Price, Quote & Chart | ABBOTT LABORATORIES (NYSE:ABT) - ChartMill
Abbott Laboratories (ABT) Q1 2026 Earnings Call Highlights: Strong Medical Devices Growth Amid ... By GuruFocus - Investing.com Canada
Inside Biotech: Abbott’s solid quarter isn’t enough as $21B bet rattles investors - Proactive financial news
Abbott Laboratories (ABT) Lowers Earnings Outlook Amid Acquisiti - GuruFocus
Abbott Laboratories (ABT) Reports Q1 2026 Earnings with Mixed Re - GuruFocus
Flu Season Fades, Abbott Stumbles: Is the 54-Year Dividend King Still Worth the Crown? - NAI500
New cancer diagnostics and product updates see Abbott Laboratories stock fall amid oversold technicals - Traders Union
Why Abbott Laboratories Stock Tumbled on Thursday - The Motley Fool
Abbott Laboratories Bets on Devices in 2026 Call - TipRanks
1.00%
0.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):